Workflow
中国波顿(03318) - 2024 - 中期财报
03318CHINA BOTON(03318)2024-09-16 04:02

Financial Performance - For the six months ended June 30, 2024, the company reported revenue of RMB 750,975,000, a decrease of 6.7% compared to RMB 805,245,000 in the same period of 2023[6] - Gross profit for the same period was RMB 305,631,000, down from RMB 328,105,000, reflecting a gross margin decline[6] - Operating profit decreased to RMB 109,237,000 from RMB 139,670,000, indicating a decline of 21.8% year-over-year[6] - The net profit attributable to the company's owners was RMB 44,332,000, down 32.2% from RMB 65,355,000 in the previous year[6] - The company's profit for the six months ended June 30, 2024, was RMB 62,682 thousand, a decrease of 27% compared to RMB 85,888 thousand in the same period of 2023[7] - Total comprehensive income for the period was RMB 59,390 thousand, down 40% from RMB 99,231 thousand year-on-year[7] - The company's net cash generated from operating activities increased to RMB 18,422 thousand, compared to RMB 8,371 thousand in the previous year, representing a 120% increase[11] - The company reported a foreign exchange loss of RMB 3,292 thousand for the period, compared to a gain of RMB 13,343 thousand in the previous year[7] - Basic earnings per share for the six months ended June 30, 2024, were RMB 0.04, down from RMB 0.06 in the same period of 2023[44] Assets and Liabilities - Total assets as of June 30, 2024, were RMB 5,869,289,000, a decrease from RMB 6,006,867,000 at the end of 2023[4] - Total liabilities decreased to RMB 2,458,964,000 from RMB 2,630,640,000, reflecting a reduction of 6.5%[4] - Cash and cash equivalents were reported at RMB 319,895,000, down from RMB 349,794,000, indicating a decrease of 8.5%[3] - The company’s inventory increased slightly to RMB 338,727,000 from RMB 330,619,000, showing a growth of 2.0%[3] - Accounts receivable as of June 30, 2024, totaled RMB 646,884 thousand, a decrease of 11.1% from RMB 728,106 thousand as of December 31, 2023[26] - The net amount of accounts receivable after expected credit loss provisions was RMB 396,950 thousand, down 18.4% from RMB 486,662 thousand as of December 31, 2023[26] - The total liabilities as of June 30, 2024, amounted to RMB 730,123 thousand, a decrease of 12.5% from RMB 834,593 thousand as of December 31, 2023[30] - The total equity as of June 30, 2024, was RMB 1,393,954 thousand, reflecting an increase from RMB 1,292,432 thousand as of December 31, 2023[28] Revenue Segmentation - The segment revenue breakdown includes RMB 313,993 thousand from flavor enhancers, RMB 90,286 thousand from food flavors, and RMB 256,132 thousand from electronic cigarette products[19] - The revenue from the electronic cigarette segment was approximately RMB 256.1 million, a significant decline of 21.6% from RMB 326.5 million in the prior year[57] - The flavor enhancer segment generated revenue of approximately RMB 308.1 million, slightly increasing by 0.7% from RMB 306 million in the previous year[53] - The food flavor segment reported revenue of approximately RMB 90.3 million, an increase of 3.4% from RMB 87.3 million in the same period last year[55] - The daily flavor segment's revenue was approximately RMB 69.6 million, up 12.3% from RMB 62 million in the previous year[56] - The investment property segment saw revenue of approximately RMB 26.9 million, an increase of 15.0% from RMB 23.4 million in the previous year[58] Expenses and Costs - Employee benefits expenses increased to RMB 96,929,000, up 11.5% from RMB 87,114,000[39] - Depreciation and amortization expenses decreased to RMB 56,326,000, down 18.2% from RMB 68,855,000[39] - Sales and marketing expenses were approximately RMB 23.6 million, representing about 3.1% of total revenue, a decrease of 33.3% compared to RMB 35.4 million in the same period last year[63] - Administrative expenses for the same period were approximately RMB 168.5 million, accounting for about 22.4% of total revenue, an increase of 2.2% from RMB 164.9 million year-on-year[63] - The net financial cost for the six months ended June 30, 2024, was RMB (28,007,000), an improvement from RMB (34,373,000) in the same period of 2023[41] Strategic Plans and Developments - The company plans to focus on new product development and market expansion strategies in the upcoming quarters[6] - The company plans to continue expanding its market presence in China and Asia, focusing on the production and sales of flavors, fragrances, and electronic cigarette products[12] - The group plans to implement new strategies in the second half of 2024, including corporate restructuring and establishing new product branding teams to adapt to the growing e-cigarette market[66] - The group has obtained production licenses for e-cigarette oil and products, ensuring compliance with national standards[66] Corporate Governance and Compliance - The company has maintained the same accounting policies as the previous fiscal year, ensuring consistency in financial reporting[14] - The company has not adopted any new accounting standards that would significantly impact its financial performance for the current or future reporting periods[15] - The company continues to evaluate its accounting estimates and judgments, which may affect reported asset and liability amounts[17] - The audit committee, composed of four independent non-executive directors, has reviewed the unaudited interim condensed consolidated financial statements for the six months ending June 30, 2024[91] - The remuneration committee is responsible for considering and approving the remuneration arrangements for senior employees, including salary and bonus plans[92] - The nomination committee reviews the board's structure and diversity, making recommendations for appointments and succession planning[93] - The company has adhered to the corporate governance code throughout the reporting period, except for the separation of the roles of chairman and CEO[94] - All directors confirmed compliance with the standard code of conduct for securities trading during the six-month period ending June 30, 2024[95] Shareholder Information - Major shareholders include Mr. Wang Mingfan with 729,456,226 shares (67.51% of issued share capital), Chuanghua Limited with 348,320,509 shares (32.24%), and Full Ashley Enterprises Limited with 19,318,234 shares (1.79%)[88] - The company has adopted a new share option plan effective from December 12, 2023, allowing for the issuance of up to 10% of the issued shares, which totals 108,051,214 shares[83] - The company has adopted a share incentive plan approved by shareholders on December 11, 2023, allowing for the issuance of ordinary shares at a par value of HKD 0.10 to eligible employees without payment at the time of grant or vesting[85] - As of June 30, 2024, there are 396,000 shares held by the trustee under the share incentive plan that have not yet been granted, with no shares granted during the reporting period[85] - The board does not recommend the distribution of interim dividends for the six months ending June 30, 2024[74] Legal and Regulatory Matters - The company completed the sale of a 51% stake in Mons Co., Ltd. and Boton Medical Co., Ltd. to an independent third party in August 2023[22] - There are ongoing legal proceedings related to the acquisition of Kimree, Inc., involving claims against former sellers for breaching non-competition agreements[79] - The company’s wholly-owned subsidiary in Shenzhen is in discussions regarding compensation for land expropriation by the government for public interest, with no specific compensation amount disclosed yet[78] - As of June 30, 2024, the company reported no significant contingent liabilities[77]